Issue 4, 2020

Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition

Abstract

Klebsiella pneumoniae carbapenemase-2 (KPC-2) is a serine-β-lactamase (SBL) capable of hydrolysing almost all β-lactam antibiotics. We compare KPC-2 inhibition by vaborbactam, a clinically-approved monocyclic boronate, and VNRX-5133 (taniborbactam), a bicyclic boronate in late-stage clinical development. Vaborbactam inhibition is slowly reversible, whereas taniborbactam has an off-rate indicating essentially irreversible complex formation and a 15-fold higher on-rate, although both potentiate β-lactam activity against KPC-2-expressing K. pneumoniae. High resolution X-ray crystal structures reveal closely related binding modes for both inhibitors to KPC-2, with differences apparent only in positioning of the endocyclic boronate ester oxygen. The results indicate the bicyclic boronate scaffold as both an efficient, long-lasting, KPC-2 inhibitor and capable of supporting further iterations that may improve potency against specific enzyme targets and pre-empt the emergence of inhibitor resistant KPC-2 variants.

Graphical abstract: Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition

Supplementary files

Article information

Article type
Research Article
Submitted
11 Nov 2019
Accepted
08 Jan 2020
First published
10 Jan 2020

RSC Med. Chem., 2020,11, 491-496

Cyclic boronates as versatile scaffolds for KPC-2 β-lactamase inhibition

C. L. Tooke, P. Hinchliffe, A. Krajnc, A. J. Mulholland, J. Brem, C. J. Schofield and J. Spencer, RSC Med. Chem., 2020, 11, 491 DOI: 10.1039/C9MD00557A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements